Friends for Life Orlando 2022 Sponsors
Diamond Level Sponsor
In 1923, the founders of Novo Nordisk began a journey to change diabetes. Today, we are thousands of employees across the world with the passion, the skills and the commitment to continue this journey to prevent, treat and ultimately cure diabetes. Novo Nordisk is proud to be a Bronze Level Sponsor of the Friends for Life conference. Please come see us at the exhibition to find out more about our company and our products. To learn more about Novo Nordisk and our support to the type 1 diabetes community, visit us at www.novonordisk-us.com.
Platinum Level Sponsors
Dexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in glucose biosensing for more than 25 years. Its technology has transformed how people manage diabetes and track their glucose, helping them feel more in control and live more confidently.
Dexcom. Discover what you’re made of. For more information, visit www.dexcom.com.
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet’s latest innovation, the Omnipod® 5 Automated Insulin Delivery System, is a tubeless automated insulin delivery system, integrated with a continuous glucose monitor to manage blood sugar with no multiple daily injections, zero fingersticks, and is fully controlled by a compatible personal smartphone. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, please visit insulet.com and omnipod.com.
Gold Level Sponsors
Abbott is a global healthcare leader helping people live more fully at all stages of life. Our FreeStyle Libre portfolio has changed the lives of more than 5.5 million people across more than 60 countries because it is simple, effective and affordable. We’re proud to sponsor the Friends for Life Orlando Conference, raising awareness for diabetes technology to help the 352,000 children and adolescents living with the condition in the U.S. today. Connect with us at https://freestyle.abbott/cwd, on Instagram at @FreeStyleDiabetes, and on Facebook at @FreeStyleUS.
Tandem Diabetes Care creates new possibilities for people living with diabetes, their loved ones, and their healthcare providers through a positively different experience. We deliver innovative products and automated insulin delivery systems — including Tandem Mobi and the t:slim X2 — to people who require insulin therapy. For more information, visit tandemdiabetes.com.
Silver Level Sponsors
The American Diabetes Association® (ADA) is the nation’s leading voluntary health organization fighting to end diabetes and helping people thrive. This year, the ADA celebrates 85 years of driving discovery and research to prevent, manage, treat, and ultimately cure —and we’re not stopping. There are 136 million Americans living with diabetes or prediabetes. Through advocacy, program development, and education, we’re fighting for them all. To learn more or to get involved, visit us at diabetes.org or call 1-800-DIABETES (800-342-2383). Join us in the fight on Facebook (American Diabetes Association), Spanish Facebook (Asociación Americana de la Diabetes), LinkedIn (American Diabetes Association), and Instagram (@AmDiabetesAssn). To learn more about how we are advocating for everyone affected by diabetes, visit us on X (@AmDiabetesAssn).
Medtronic Diabetes is on a mission to alleviate the burden of diabetes by empowering individuals to live life on their terms, with the most advanced technology and always-on support when and how it is needed. Medtronic has pioneered first-of-its-kind innovations for over 40 years and is committed to designing the future of diabetes management through next-generation sensors (CGM), intelligent dosing systems, and the power of data science and AI while always putting the customer experience at the forefront. Today we offer the MiniMed™ 780G insulin pump system, the InPen™ smart insulin pen and the i-Port Advance™ injection port, and we continue to innovate further. With a renewed focus on creating products that are easy to use, we hope our future technologies will enable people to focus more on life, and not diabetes. To learn more, visit www.medtronicdiabetes.com and follow us on Facebook, Instagram, TikTok, YouTube and LinkedIn.
VIATRIS is a new kind of healthcare company, committed to providing access to medicines, advancing sustainable operations and developing innovative solutions. Formed in 2020 through the combination of Mylan and Upjohn, Viatris brings together manufacturing and distribution expertise with proven regulatory, medical and commercial capabilities.
*Page intended for U.S. Healthcare Providers.
Bronze Level Sponsors
We’re a medicine company turning science into healing to make life better for people around the world.
Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world’s most significant health challenges. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: “Take what you find here and make it better and better.”
But we’re not only dedicated to making medicines. We go beyond medicine to deliver innovative clinical trials that reflect the diversity of our world and work to ensure our medicines are accessible and affordable. Learn more at www.lilly.com/who-we-are/about-lilly.
Xeris Pharmaceuticals, Inc., the maker of Gvoke HypoPen® (glucagon injection), is dedicated to unlocking the potential of glucagon. We believe that our technology can have a profound impact on the lives of patients and their families. That’s why we are proud to be the first to develop liquid glucagon, but that’s just the beginning. We’re also studying how our formulation technology can impact patients with other conditions. We have a persistent drive to pursue solutions that have the potential to change lives. Get to know us and see how our technology is unlocking the potential of today’s medicines at www.xerispharma.com
Friends of CWD
Beta Bionics is a medical technology company focused on the design, development, and commercialization of its iLet Bionic Pancreas in both the single hormone and bi-hormonal configurations. The iLet Bionic Pancreas platform is designed to use adaptive, self-learning, control algorithms, together with continuous glucose monitoring and pump technology, to autonomously compute and administer doses of insulin and/or glucagon and mimic the body’s natural ability to maintain tight glycemic control, relieving some of the burden of living with diabetes. To learn more, visit http://www.betabionics.com.
Formed in 1986, the Certification Board for Diabetes Care and Education (CBDCE) is a national, not-for-profit certification board that administers the Certified Diabetes Care and Education Specialist® (CDCES®) and the Board Certified-
Advanced Diabetes Management (BC-ADM®) credential programs. Over 20,800 health professionals are credentialed in the diabetes care and education community. CDCESs are committed and passionate about their work in partnership with people with diabetes and their families and caregivers.
Diabeloop gathers the personality, passion, and skills of over 100 talented individuals, many of whom are personally touched by insulin-dependent diabetes. Founded in Grenoble, France in 2015, Diabeloop is a high-growth company that is developing AI-based, personalized solutions to improve clinical outcomes for people with diabetes while relieving their constant mental burden.
The JDRF – Beyond Type 1 Alliance provides greater support for those impacted by type 1 diabetes by tapping into the combined power of JDRF, the leading global organization funding T1D research, and Beyond Type 1, the organization with the largest online community of any diabetes nonprofit. The work of the Alliance centers around three core pillars: community programs, advocacy, and communications + education.
MannKind is committed to providing products that allow people living with diabetes to experience life without limits. With Afrezza ® (insulin human) Inhalation Powder and V-Go ® wearable insulin delivery MannKind is focused on being a leader in mealtime control to address this serious unmet need within the diabetes community. Enrollment is currently underway for the INHALE-1 study that is evaluating Afrezza (in combination with basal insulin) for youth aged 4-17 living with type 1 or type 2 diabetes. With a passionate team of Mannitarians collaborating nationwide, we are on a mission to give people control of their health and the freedom to live life. Visit us at mannkindcorp.com and learn more about INHALE-1 at clinicaltrials.gov.
Provention Bio, Inc. (Nasdaq: PRVB) is a biopharmaceutical company focused on advancing the development of investigational therapies that may intercept and prevent debilitating and life-threatening immune-mediated disease. The Company’s pipeline includes a late-stage product candidate for type 1 diabetes (T1D) as well as clinical drug candidates in other autoimmune diseases, including celiac disease and lupus. We are proud to be part of the T1D ecosystem and are committed to bringing awareness to the importance and urgency of screening people with a family history of T1D for early-stage disease. Visit ProventionBio.com for more information or follow us on Twitter: @ProventionBio.
SafetyIsThePoint helps people understand how to dispose of used household sharps safely, no matter where they live, work or travel in the United States. The site has a ZIP code locator and free resources about safe sharps disposal. It is a free public education campaign supported by a coalition of leading biopharmaceutical and medical device manufacturers: BD, Biogen, Dexcom, Eli Lilly and Company, Roche, and Sanofi US. Visit SafetyIsThePoint.org.
T1D Exchange is a nonprofit that fosters collaboration and delivers research insights to improve every person’s experience of living with diabetes. We use real-world data and the lived experience of people with type 1 diabetes to improve T1D management and outcomes. The T1D Exchange Registry is our research study in which participants answer a survey once per year. It is open to adults and children with T1D living in the United States. Through our registry, more than 20,000 people with T1D share their experiences and participate in research that drives real change with measurable results. After completing a quick survey, participants get access to an online research dashboard, where they can find opportunities to participate in surveys, clinical trials, at-home studies, and more!
At 10 years old Elizabeth Forrest was diagnosed with type 1 diabetes and soon after declared diabetes wasn’t going to control her. Inspired by her middle school dance class, she combined her love for dance with her new diagnosis and created Dancing for Diabetes® as a way to bring attention to the millions who are living with Type 1 Diabetes and to raise funds to find a cure. Dancing for Diabetes® became a springboard for additional impactful programs that now make up the Touched by Type 1 organization which include: Dancing for Diabetes®, Kids & Teens with Diabetes Dance program, Type 1 @ School, Touched by Type 1 Annual Conference, Outreach, and the D-Box. Until a cure is found, Touched by Type 1 will continue to elevate awareness of Type 1 Diabetes, raise funds to find a cure, and inspire those with diabetes to thrive.